Using pooled urogenital, anorectal and oropharyngeal specimens to detect
diagnostic microbiology
health economics
public health
sexually transmitted disease
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
06 03 2023
06 03 2023
Historique:
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
9
3
2023
Statut:
epublish
Résumé
Screening for Diagnostic accuracy study. Participants were recruited from MSM communities at six cities in China. Two oropharyngeal and anorectal swabs collected by clinical staff and 20 mL first-void urine collected by the participant himself were used for evaluating sensitivity and specificity. A total of 1311 specimens were collected from 437 participants in six cities. The sensitivities of ex-ante pooling approach as compared with single-specimen approach (reference standard) were 98.7% (95% CI, 92.7% to 100.0%) for detection of CT and 89.7% (95% CI, 75.8% to 97.1%) for NG, and the specificities were 99.5% (95% CI, 98.0% to 99.9%) and 98.7% (95% CI, 97.1% to 99.6%), respectively. The sensitivities of ex-post pooling approach were 98.7% (95% CI, 92.7% to 100.0%) for CT and 100.0% (95% CI, 91.0% to 100.0%) for NG, and the specificities were 100.0% (95% CI, 99.0% to 100.0%) and 100.0% (95% CI, 99.1% to 100.0%), respectively. The ex-ante and ex-post pooling approaches show good sensitivity and specificity in detecting urogenital and extragenital CT and/or NG, indicating that these approaches can be used in epidemiological surveillance and clinical management of CT and NG infections, particularly among MSM population.
Identifiants
pubmed: 36878660
pii: bmjopen-2022-069876
doi: 10.1136/bmjopen-2022-069876
pmc: PMC9990619
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e069876Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 1985 Mar 8;253(10):1417-9
pubmed: 3155806
BMC Infect Dis. 2019 Dec 10;19(1):1041
pubmed: 31823768
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
Sex Transm Dis. 2018 Mar;45(3):195-198
pubmed: 29419710
Sex Transm Infect. 2021 Sep;97(6):471-472
pubmed: 33188137
Int J STD AIDS. 2018 Jan 1;:956462417746897
pubmed: 29334885
J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1353-63
pubmed: 19522706
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132192
J Clin Microbiol. 2016 Mar;54(3):650-6
pubmed: 26719439
Sex Health. 2019 Aug;16(4):314-319
pubmed: 31296280
Infect Dis Obstet Gynecol. 2016;2016:5758387
pubmed: 27366021
N Engl J Med. 2021 Jun 24;384(25):2418-2427
pubmed: 34161706
Expert Rev Mol Diagn. 2013 Mar;13(2):131-40
pubmed: 23477553
Front Cell Infect Microbiol. 2022 Jan 03;11:784610
pubmed: 35047416
Sex Health. 2020 Feb;17(1):15-21
pubmed: 31945307
Sex Transm Infect. 2018 Jun;94(4):293-297
pubmed: 29066627
Sex Transm Dis. 2021 Oct 1;48(10):733-737
pubmed: 34110736
Syst Rev. 2021 Apr 19;10(1):118
pubmed: 33879251
Sex Transm Infect. 2021 Aug;97(5):324-328
pubmed: 33082236
Sex Transm Dis. 2020 Aug;47(8):556-561
pubmed: 32355106
Acta Clin Belg. 2020 Apr;75(2):91-95
pubmed: 30415606
Clin Infect Dis. 2021 Nov 2;73(9):e3183-e3193
pubmed: 33044490